Home › Funds › Context Capital Management, LLC › NUVB
Context Capital Management, LLC position in NUVB
NUVATION BIO INC · Health Care
Context Capital Management, LLC reported holding 52,000,000 shares of NUVB (NUVATION BIO INC) in its Q3 2026 13F filing — a position valued at US$53.1M, representing 1.76% of its reported portfolio and ranking #21 among its reported holdings. Context Capital Management, LLC has disclosed NUVB holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Context Capital Management, LLC's NUVB position evolved
Context Capital Management, LLC first disclosed a stake in NUVB in Q2 2026 at 30,000,000 shares (US$31.3M). The position peaked in Q3 2026 at 52,000,000 shares, worth US$53.1M. Across 2 filings, Context Capital Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 52,000,000 shares valued at US$53.1M — an increase of 22,000,000 shares quarter over quarter.. Notable position changes include a 73% increase in Q3 2026 (shares fell 23% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 30.00M | $31.29M | New |
| Q3 2026 | 52.00M | $53.13M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NUVB and 13F data
NUVB (NUVATION BIO INC) is a Health Care company. 54 other funds we track also report a position in NUVB — the largest reported positions include Decheng Capital LLC (US$147.4M), Omega Fund Management, LLC (US$45.9M), Laurion Capital Management LP (US$43.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NUVB
- Decheng Capital LLC 25.95M sh · $147.42M · Q2 2026
- Omega Fund Management, LLC 8.08M sh · $45.90M · Q2 2026
- Laurion Capital Management LP 7.70M sh · $43.10M · Q3 2026
- Polar Asset Management Partners Inc. 25.00M sh · $26.10M · Q2 2026
- Duquesne Family Office LLC 4.54M sh · $25.79M · Q2 2026
- Jones Hill Capital LP 4.49M sh · $25.13M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 3.30M sh · $18.74M · Q2 2026
- Redmile Group, LLC 3.03M sh · $17.22M · Q2 2026
- Knoll Capital Management, LLC 1.60M sh · $9.08M · Q2 2026
- ESSEX INVESTMENT MANAGEMENT CO LLC 1.34M sh · $7.53M · Q3 2026
- ABRAMS CAPITAL MANAGEMENT, L.P. 1.27M sh · $7.22M · Q2 2026
More on Context Capital Management, LLC
FAQ
How long has Context Capital Management, LLC held NUVB?
Context Capital Management, LLC has disclosed NUVB holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Context Capital Management, LLC's current position in NUVB?
As of Q3 2026, Context Capital Management, LLC holds 52.00M shares of NUVB (NUVATION BIO INC), valued at $53.13M, representing 1.76% of its reported portfolio and ranking #21.
Has Context Capital Management, LLC been buying or selling NUVB?
In the latest 13F filing (Q3 2026), Context Capital Management, LLC increased its position in NUVB. The position peaked in Q3 2026 at 52.00M shares.
Which other funds hold NUVB?
Other major institutional holders of NUVB include Decheng Capital LLC, Omega Fund Management, LLC, Laurion Capital Management LP, among 54 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.